nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—CYP2D6—Labetalol—hypertension	0.048	0.079	CbGbCtD
Methylnaltrexone—CYP2D6—Nebivolol—hypertension	0.048	0.079	CbGbCtD
Methylnaltrexone—CYP2D6—Acebutolol—hypertension	0.0439	0.0722	CbGbCtD
Methylnaltrexone—CYP2D6—Metoprolol—hypertension	0.0408	0.0672	CbGbCtD
Methylnaltrexone—CYP2D6—Pindolol—hypertension	0.0408	0.0672	CbGbCtD
Methylnaltrexone—CYP2D6—Betaxolol—hypertension	0.0364	0.0599	CbGbCtD
Methylnaltrexone—CYP2D6—Doxazosin—hypertension	0.032	0.0527	CbGbCtD
Methylnaltrexone—CYP2D6—Diltiazem—hypertension	0.0309	0.0509	CbGbCtD
Methylnaltrexone—CYP2D6—Bepridil—hypertension	0.0276	0.0454	CbGbCtD
Methylnaltrexone—CYP2D6—Irbesartan—hypertension	0.0252	0.0415	CbGbCtD
Methylnaltrexone—CYP2D6—Amlodipine—hypertension	0.0247	0.0407	CbGbCtD
Methylnaltrexone—CYP2D6—Felodipine—hypertension	0.0238	0.0392	CbGbCtD
Methylnaltrexone—CYP2D6—Timolol—hypertension	0.0234	0.0386	CbGbCtD
Methylnaltrexone—CYP2D6—Nifedipine—hypertension	0.0231	0.038	CbGbCtD
Methylnaltrexone—CYP2D6—Nicardipine—hypertension	0.0227	0.0374	CbGbCtD
Methylnaltrexone—CYP2D6—Carvedilol—hypertension	0.0227	0.0374	CbGbCtD
Methylnaltrexone—CYP2D6—Propranolol—hypertension	0.0209	0.0344	CbGbCtD
Methylnaltrexone—CYP2D6—Captopril—hypertension	0.0206	0.034	CbGbCtD
Methylnaltrexone—CYP2D6—Clonidine—hypertension	0.0199	0.0328	CbGbCtD
Methylnaltrexone—CYP2D6—Atorvastatin—hypertension	0.0178	0.0292	CbGbCtD
Methylnaltrexone—CYP2D6—Verapamil—hypertension	0.0143	0.0236	CbGbCtD
Methylnaltrexone—Buprenorphine—CYP2C18—hypertension	0.000861	0.322	CrCbGaD
Methylnaltrexone—Oxycodone—CYP3A5—hypertension	0.000615	0.231	CrCbGaD
Methylnaltrexone—Buprenorphine—CYP3A5—hypertension	0.000567	0.212	CrCbGaD
Methylnaltrexone—Hydromorphone—PTGS1—hypertension	0.000414	0.155	CrCbGaD
Methylnaltrexone—Nausea—Nicardipine—hypertension	0.000321	0.00134	CcSEcCtD
Methylnaltrexone—Oedema—Enalapril—hypertension	0.00032	0.00134	CcSEcCtD
Methylnaltrexone—Skin disorder—Clonidine—hypertension	0.00032	0.00134	CcSEcCtD
Methylnaltrexone—Diarrhoea—Nisoldipine—hypertension	0.00032	0.00134	CcSEcCtD
Methylnaltrexone—Diarrhoea—Amlodipine—hypertension	0.00032	0.00134	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Indapamide—hypertension	0.000319	0.00134	CcSEcCtD
Methylnaltrexone—Abdominal pain—Propranolol—hypertension	0.000319	0.00133	CcSEcCtD
Methylnaltrexone—Vomiting—Acebutolol—hypertension	0.000319	0.00133	CcSEcCtD
Methylnaltrexone—Pain—Nifedipine—hypertension	0.000319	0.00133	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Clonidine—hypertension	0.000318	0.00133	CcSEcCtD
Methylnaltrexone—Dizziness—Eprosartan—hypertension	0.000318	0.00133	CcSEcCtD
Methylnaltrexone—Pain—Verapamil—hypertension	0.000317	0.00133	CcSEcCtD
Methylnaltrexone—Nausea—Metolazone—hypertension	0.000317	0.00133	CcSEcCtD
Methylnaltrexone—Nausea—Felodipine—hypertension	0.000317	0.00133	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Carvedilol—hypertension	0.000316	0.00132	CcSEcCtD
Methylnaltrexone—Nausea—Spironolactone—hypertension	0.000316	0.00132	CcSEcCtD
Methylnaltrexone—Vomiting—Labetalol—hypertension	0.000316	0.00132	CcSEcCtD
Methylnaltrexone—Oedema—Telmisartan—hypertension	0.000316	0.00132	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Trandolapril—hypertension	0.000315	0.00132	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Doxazosin—hypertension	0.000313	0.00131	CcSEcCtD
Methylnaltrexone—Skin disorder—Trandolapril—hypertension	0.000312	0.0013	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Trandolapril—hypertension	0.000311	0.0013	CcSEcCtD
Methylnaltrexone—Nausea—Esmolol—hypertension	0.00031	0.00129	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Telmisartan—hypertension	0.000309	0.00129	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Enalapril—hypertension	0.000309	0.00129	CcSEcCtD
Methylnaltrexone—Dizziness—Nisoldipine—hypertension	0.000309	0.00129	CcSEcCtD
Methylnaltrexone—Dizziness—Amlodipine—hypertension	0.000309	0.00129	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Fosinopril—hypertension	0.000309	0.00129	CcSEcCtD
Methylnaltrexone—Abdominal pain—Indapamide—hypertension	0.000309	0.00129	CcSEcCtD
Methylnaltrexone—Abdominal pain—Diltiazem—hypertension	0.000309	0.00129	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Perindopril—hypertension	0.000309	0.00129	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—hypertension	0.000308	0.00129	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Eplerenone—hypertension	0.000307	0.00128	CcSEcCtD
Methylnaltrexone—Skin disorder—Telmisartan—hypertension	0.000307	0.00128	CcSEcCtD
Methylnaltrexone—Vomiting—Eprosartan—hypertension	0.000306	0.00128	CcSEcCtD
Methylnaltrexone—Abdominal pain—Carvedilol—hypertension	0.000306	0.00128	CcSEcCtD
Methylnaltrexone—Nausea—Terazosin—hypertension	0.000306	0.00128	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Telmisartan—hypertension	0.000305	0.00128	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Nifedipine—hypertension	0.000305	0.00127	CcSEcCtD
Methylnaltrexone—Abdominal pain—Doxazosin—hypertension	0.000302	0.00126	CcSEcCtD
Methylnaltrexone—Diarrhoea—Guanabenz—hypertension	0.000301	0.00126	CcSEcCtD
Methylnaltrexone—Diarrhoea—Metoprolol—hypertension	0.000301	0.00126	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—hypertension	0.0003	0.00125	CcSEcCtD
Methylnaltrexone—Abdominal pain—Fosinopril—hypertension	0.000299	0.00125	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Valsartan—hypertension	0.000298	0.00125	CcSEcCtD
Methylnaltrexone—Oedema—Perindopril—hypertension	0.000298	0.00125	CcSEcCtD
Methylnaltrexone—Nausea—Acebutolol—hypertension	0.000298	0.00125	CcSEcCtD
Methylnaltrexone—Vomiting—Amlodipine—hypertension	0.000297	0.00124	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—hypertension	0.000297	0.00124	CcSEcCtD
Methylnaltrexone—Oedema—Irbesartan—hypertension	0.000297	0.00124	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Olmesartan—hypertension	0.000297	0.00124	CcSEcCtD
Methylnaltrexone—Abdominal pain—Eplerenone—hypertension	0.000297	0.00124	CcSEcCtD
Methylnaltrexone—Nausea—Labetalol—hypertension	0.000295	0.00123	CcSEcCtD
Methylnaltrexone—Abdominal pain—Nifedipine—hypertension	0.000295	0.00123	CcSEcCtD
Methylnaltrexone—Oedema—Hydrochlorothiazide—hypertension	0.000295	0.00123	CcSEcCtD
Methylnaltrexone—Pain—Olmesartan—hypertension	0.000294	0.00123	CcSEcCtD
Methylnaltrexone—Erythema—Ramipril—hypertension	0.000294	0.00123	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Perindopril—hypertension	0.000292	0.00122	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Irbesartan—hypertension	0.000291	0.00122	CcSEcCtD
Methylnaltrexone—Dizziness—Guanabenz—hypertension	0.000291	0.00121	CcSEcCtD
Methylnaltrexone—Dizziness—Metoprolol—hypertension	0.000291	0.00121	CcSEcCtD
Methylnaltrexone—Skin disorder—Perindopril—hypertension	0.000289	0.00121	CcSEcCtD
Methylnaltrexone—Skin disorder—Irbesartan—hypertension	0.000288	0.00121	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Perindopril—hypertension	0.000288	0.0012	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Irbesartan—hypertension	0.000287	0.0012	CcSEcCtD
Methylnaltrexone—Erythema—Timolol—hypertension	0.000287	0.0012	CcSEcCtD
Methylnaltrexone—Oedema—Betaxolol—hypertension	0.000287	0.0012	CcSEcCtD
Methylnaltrexone—Nausea—Eprosartan—hypertension	0.000286	0.0012	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Hydrochlorothiazide—hypertension	0.000285	0.00119	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Clonidine—hypertension	0.000284	0.00119	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Furosemide—hypertension	0.000284	0.00119	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Valsartan—hypertension	0.000283	0.00118	CcSEcCtD
Methylnaltrexone—Pain—Clonidine—hypertension	0.000282	0.00118	CcSEcCtD
Methylnaltrexone—Skin disorder—Furosemide—hypertension	0.000281	0.00118	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Betaxolol—hypertension	0.000281	0.00118	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Olmesartan—hypertension	0.000281	0.00118	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Furosemide—hypertension	0.00028	0.00117	CcSEcCtD
Methylnaltrexone—Oedema—Losartan—hypertension	0.000279	0.00117	CcSEcCtD
Methylnaltrexone—Vomiting—Metoprolol—hypertension	0.000279	0.00117	CcSEcCtD
Methylnaltrexone—Vomiting—Guanabenz—hypertension	0.000279	0.00117	CcSEcCtD
Methylnaltrexone—Skin disorder—Betaxolol—hypertension	0.000279	0.00116	CcSEcCtD
Methylnaltrexone—Nausea—Nisoldipine—hypertension	0.000278	0.00116	CcSEcCtD
Methylnaltrexone—Nausea—Amlodipine—hypertension	0.000278	0.00116	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Trandolapril—hypertension	0.000277	0.00116	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Betaxolol—hypertension	0.000277	0.00116	CcSEcCtD
Methylnaltrexone—Diarrhoea—Propranolol—hypertension	0.000276	0.00115	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Losartan—hypertension	0.000274	0.00115	CcSEcCtD
Methylnaltrexone—Abdominal pain—Valsartan—hypertension	0.000273	0.00114	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Telmisartan—hypertension	0.000272	0.00114	CcSEcCtD
Methylnaltrexone—Abdominal pain—Olmesartan—hypertension	0.000272	0.00114	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Losartan—hypertension	0.00027	0.00113	CcSEcCtD
Methylnaltrexone—Pain—Telmisartan—hypertension	0.00027	0.00113	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Clonidine—hypertension	0.000269	0.00113	CcSEcCtD
Methylnaltrexone—Diarrhoea—Diltiazem—hypertension	0.000267	0.00112	CcSEcCtD
Methylnaltrexone—Diarrhoea—Indapamide—hypertension	0.000267	0.00112	CcSEcCtD
Methylnaltrexone—Dizziness—Propranolol—hypertension	0.000267	0.00112	CcSEcCtD
Methylnaltrexone—Erythema—Lisinopril—hypertension	0.000266	0.00111	CcSEcCtD
Methylnaltrexone—Diarrhoea—Carvedilol—hypertension	0.000265	0.00111	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Trandolapril—hypertension	0.000263	0.0011	CcSEcCtD
Methylnaltrexone—Flatulence—Lisinopril—hypertension	0.000262	0.0011	CcSEcCtD
Methylnaltrexone—Diarrhoea—Doxazosin—hypertension	0.000262	0.00109	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Enalapril—hypertension	0.000262	0.00109	CcSEcCtD
Methylnaltrexone—Nausea—Guanabenz—hypertension	0.000261	0.00109	CcSEcCtD
Methylnaltrexone—Nausea—Metoprolol—hypertension	0.000261	0.00109	CcSEcCtD
Methylnaltrexone—Abdominal pain—Clonidine—hypertension	0.00026	0.00109	CcSEcCtD
Methylnaltrexone—Diarrhoea—Fosinopril—hypertension	0.000258	0.00108	CcSEcCtD
Methylnaltrexone—Dizziness—Diltiazem—hypertension	0.000258	0.00108	CcSEcCtD
Methylnaltrexone—Dizziness—Indapamide—hypertension	0.000258	0.00108	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Telmisartan—hypertension	0.000258	0.00108	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Perindopril—hypertension	0.000257	0.00108	CcSEcCtD
Methylnaltrexone—Diarrhoea—Eplerenone—hypertension	0.000257	0.00107	CcSEcCtD
Methylnaltrexone—Vomiting—Propranolol—hypertension	0.000257	0.00107	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Irbesartan—hypertension	0.000256	0.00107	CcSEcCtD
Methylnaltrexone—Dizziness—Carvedilol—hypertension	0.000256	0.00107	CcSEcCtD
Methylnaltrexone—Diarrhoea—Nifedipine—hypertension	0.000255	0.00107	CcSEcCtD
Methylnaltrexone—Pain—Perindopril—hypertension	0.000255	0.00107	CcSEcCtD
Methylnaltrexone—Abdominal pain—Trandolapril—hypertension	0.000254	0.00106	CcSEcCtD
Methylnaltrexone—Diarrhoea—Verapamil—hypertension	0.000254	0.00106	CcSEcCtD
Methylnaltrexone—Pain—Irbesartan—hypertension	0.000254	0.00106	CcSEcCtD
Methylnaltrexone—Dizziness—Doxazosin—hypertension	0.000253	0.00106	CcSEcCtD
Methylnaltrexone—Abdominal pain—Enalapril—hypertension	0.000253	0.00106	CcSEcCtD
Methylnaltrexone—Pain—Hydrochlorothiazide—hypertension	0.000252	0.00105	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Captopril—hypertension	0.000251	0.00105	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Furosemide—hypertension	0.00025	0.00105	CcSEcCtD
Methylnaltrexone—Dizziness—Fosinopril—hypertension	0.00025	0.00104	CcSEcCtD
Methylnaltrexone—Abdominal pain—Telmisartan—hypertension	0.000249	0.00104	CcSEcCtD
Methylnaltrexone—Dizziness—Eplerenone—hypertension	0.000248	0.00104	CcSEcCtD
Methylnaltrexone—Vomiting—Diltiazem—hypertension	0.000248	0.00104	CcSEcCtD
Methylnaltrexone—Vomiting—Indapamide—hypertension	0.000248	0.00104	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	0.000248	0.00104	CcSEcCtD
Methylnaltrexone—Pain—Furosemide—hypertension	0.000248	0.00104	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Betaxolol—hypertension	0.000248	0.00104	CcSEcCtD
Methylnaltrexone—Dizziness—Nifedipine—hypertension	0.000246	0.00103	CcSEcCtD
Methylnaltrexone—Vomiting—Carvedilol—hypertension	0.000246	0.00103	CcSEcCtD
Methylnaltrexone—Dizziness—Verapamil—hypertension	0.000245	0.00103	CcSEcCtD
Methylnaltrexone—Pain—Betaxolol—hypertension	0.000245	0.00103	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Perindopril—hypertension	0.000244	0.00102	CcSEcCtD
Methylnaltrexone—Vomiting—Doxazosin—hypertension	0.000243	0.00102	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Irbesartan—hypertension	0.000243	0.00102	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	0.000243	0.00101	CcSEcCtD
Methylnaltrexone—Abdominal pain—Captopril—hypertension	0.000243	0.00101	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Hydrochlorothiazide—hypertension	0.000241	0.00101	CcSEcCtD
Methylnaltrexone—Vomiting—Fosinopril—hypertension	0.00024	0.001	CcSEcCtD
Methylnaltrexone—Nausea—Propranolol—hypertension	0.00024	0.001	CcSEcCtD
Methylnaltrexone—Oedema—Ramipril—hypertension	0.00024	0.001	CcSEcCtD
Methylnaltrexone—Pain—Losartan—hypertension	0.000239	0.000999	CcSEcCtD
Methylnaltrexone—Vomiting—Eplerenone—hypertension	0.000239	0.000998	CcSEcCtD
Methylnaltrexone—Vomiting—Nifedipine—hypertension	0.000237	0.000991	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Furosemide—hypertension	0.000237	0.00099	CcSEcCtD
Methylnaltrexone—Diarrhoea—Valsartan—hypertension	0.000236	0.000988	CcSEcCtD
Methylnaltrexone—Vomiting—Verapamil—hypertension	0.000236	0.000987	CcSEcCtD
Methylnaltrexone—Abdominal pain—Perindopril—hypertension	0.000236	0.000985	CcSEcCtD
Methylnaltrexone—Diarrhoea—Olmesartan—hypertension	0.000235	0.000984	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Ramipril—hypertension	0.000235	0.000982	CcSEcCtD
Methylnaltrexone—Abdominal pain—Irbesartan—hypertension	0.000235	0.000981	CcSEcCtD
Methylnaltrexone—Oedema—Timolol—hypertension	0.000234	0.000979	CcSEcCtD
Methylnaltrexone—Abdominal pain—Hydrochlorothiazide—hypertension	0.000233	0.000973	CcSEcCtD
Methylnaltrexone—Skin disorder—Ramipril—hypertension	0.000233	0.000973	CcSEcCtD
Methylnaltrexone—Nausea—Indapamide—hypertension	0.000232	0.00097	CcSEcCtD
Methylnaltrexone—Nausea—Diltiazem—hypertension	0.000232	0.00097	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Ramipril—hypertension	0.000232	0.000969	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Timolol—hypertension	0.00023	0.00096	CcSEcCtD
Methylnaltrexone—Nausea—Carvedilol—hypertension	0.00023	0.00096	CcSEcCtD
Methylnaltrexone—Abdominal pain—Furosemide—hypertension	0.000229	0.000957	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Losartan—hypertension	0.000229	0.000955	CcSEcCtD
Methylnaltrexone—Dizziness—Valsartan—hypertension	0.000228	0.000955	CcSEcCtD
Methylnaltrexone—Skin disorder—Timolol—hypertension	0.000228	0.000951	CcSEcCtD
Methylnaltrexone—Dizziness—Olmesartan—hypertension	0.000227	0.000951	CcSEcCtD
Methylnaltrexone—Nausea—Doxazosin—hypertension	0.000227	0.00095	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Timolol—hypertension	0.000226	0.000947	CcSEcCtD
Methylnaltrexone—Diarrhoea—Clonidine—hypertension	0.000225	0.000942	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	0.000225	0.000941	CcSEcCtD
Methylnaltrexone—Nausea—Fosinopril—hypertension	0.000224	0.000938	CcSEcCtD
Methylnaltrexone—Nausea—Eplerenone—hypertension	0.000223	0.000933	CcSEcCtD
Methylnaltrexone—Nausea—Nifedipine—hypertension	0.000221	0.000926	CcSEcCtD
Methylnaltrexone—Abdominal pain—Losartan—hypertension	0.000221	0.000924	CcSEcCtD
Methylnaltrexone—Nausea—Verapamil—hypertension	0.00022	0.000922	CcSEcCtD
Methylnaltrexone—Diarrhoea—Trandolapril—hypertension	0.00022	0.000919	CcSEcCtD
Methylnaltrexone—Vomiting—Valsartan—hypertension	0.00022	0.000919	CcSEcCtD
Methylnaltrexone—Diarrhoea—Enalapril—hypertension	0.000219	0.000915	CcSEcCtD
Methylnaltrexone—Vomiting—Olmesartan—hypertension	0.000219	0.000914	CcSEcCtD
Methylnaltrexone—Dizziness—Clonidine—hypertension	0.000218	0.000911	CcSEcCtD
Methylnaltrexone—Oedema—Lisinopril—hypertension	0.000217	0.000909	CcSEcCtD
Methylnaltrexone—Diarrhoea—Telmisartan—hypertension	0.000216	0.000903	CcSEcCtD
Methylnaltrexone—Naloxone—ALB—hypertension	0.000212	0.0796	CrCbGaD
Methylnaltrexone—Dizziness—Trandolapril—hypertension	0.000212	0.000888	CcSEcCtD
Methylnaltrexone—Dizziness—Enalapril—hypertension	0.000212	0.000885	CcSEcCtD
Methylnaltrexone—Skin disorder—Lisinopril—hypertension	0.000211	0.000883	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Lisinopril—hypertension	0.00021	0.000878	CcSEcCtD
Methylnaltrexone—Diarrhoea—Captopril—hypertension	0.00021	0.000878	CcSEcCtD
Methylnaltrexone—Vomiting—Clonidine—hypertension	0.000209	0.000876	CcSEcCtD
Methylnaltrexone—Dizziness—Telmisartan—hypertension	0.000209	0.000872	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Ramipril—hypertension	0.000207	0.000865	CcSEcCtD
Methylnaltrexone—Nausea—Valsartan—hypertension	0.000205	0.000858	CcSEcCtD
Methylnaltrexone—Nausea—Olmesartan—hypertension	0.000204	0.000854	CcSEcCtD
Methylnaltrexone—Vomiting—Trandolapril—hypertension	0.000204	0.000854	CcSEcCtD
Methylnaltrexone—Diarrhoea—Perindopril—hypertension	0.000204	0.000852	CcSEcCtD
Methylnaltrexone—Vomiting—Enalapril—hypertension	0.000203	0.000851	CcSEcCtD
Methylnaltrexone—Diarrhoea—Irbesartan—hypertension	0.000203	0.000849	CcSEcCtD
Methylnaltrexone—Dizziness—Captopril—hypertension	0.000203	0.000848	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Timolol—hypertension	0.000202	0.000846	CcSEcCtD
Methylnaltrexone—Diarrhoea—Hydrochlorothiazide—hypertension	0.000202	0.000843	CcSEcCtD
Methylnaltrexone—Vomiting—Telmisartan—hypertension	0.000201	0.000839	CcSEcCtD
Methylnaltrexone—Pain—Timolol—hypertension	0.0002	0.000838	CcSEcCtD
Methylnaltrexone—Diarrhoea—Furosemide—hypertension	0.000198	0.000829	CcSEcCtD
Methylnaltrexone—Dizziness—Perindopril—hypertension	0.000197	0.000824	CcSEcCtD
Methylnaltrexone—Dizziness—Irbesartan—hypertension	0.000196	0.000821	CcSEcCtD
Methylnaltrexone—Diarrhoea—Betaxolol—hypertension	0.000196	0.00082	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Ramipril—hypertension	0.000196	0.000819	CcSEcCtD
Methylnaltrexone—Nausea—Clonidine—hypertension	0.000196	0.000818	CcSEcCtD
Methylnaltrexone—Vomiting—Captopril—hypertension	0.000195	0.000816	CcSEcCtD
Methylnaltrexone—Dizziness—Hydrochlorothiazide—hypertension	0.000195	0.000814	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Timolol—hypertension	0.000192	0.000801	CcSEcCtD
Methylnaltrexone—Dizziness—Furosemide—hypertension	0.000192	0.000801	CcSEcCtD
Methylnaltrexone—Diarrhoea—Losartan—hypertension	0.000191	0.000799	CcSEcCtD
Methylnaltrexone—Nausea—Trandolapril—hypertension	0.000191	0.000798	CcSEcCtD
Methylnaltrexone—Nausea—Enalapril—hypertension	0.00019	0.000795	CcSEcCtD
Methylnaltrexone—Dizziness—Betaxolol—hypertension	0.00019	0.000793	CcSEcCtD
Methylnaltrexone—Vomiting—Perindopril—hypertension	0.000189	0.000792	CcSEcCtD
Methylnaltrexone—Abdominal pain—Ramipril—hypertension	0.000189	0.000792	CcSEcCtD
Methylnaltrexone—Vomiting—Irbesartan—hypertension	0.000189	0.000789	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Lisinopril—hypertension	0.000188	0.000784	CcSEcCtD
Methylnaltrexone—Nausea—Telmisartan—hypertension	0.000187	0.000784	CcSEcCtD
Methylnaltrexone—Vomiting—Hydrochlorothiazide—hypertension	0.000187	0.000783	CcSEcCtD
Methylnaltrexone—Pain—Lisinopril—hypertension	0.000186	0.000777	CcSEcCtD
Methylnaltrexone—Abdominal pain—Timolol—hypertension	0.000185	0.000774	CcSEcCtD
Methylnaltrexone—Dizziness—Losartan—hypertension	0.000185	0.000773	CcSEcCtD
Methylnaltrexone—Vomiting—Furosemide—hypertension	0.000184	0.00077	CcSEcCtD
Methylnaltrexone—Vomiting—Betaxolol—hypertension	0.000182	0.000762	CcSEcCtD
Methylnaltrexone—Nausea—Captopril—hypertension	0.000182	0.000762	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Lisinopril—hypertension	0.000178	0.000743	CcSEcCtD
Methylnaltrexone—Vomiting—Losartan—hypertension	0.000178	0.000743	CcSEcCtD
Methylnaltrexone—Nausea—Perindopril—hypertension	0.000177	0.00074	CcSEcCtD
Methylnaltrexone—Nausea—Irbesartan—hypertension	0.000176	0.000737	CcSEcCtD
Methylnaltrexone—Nausea—Hydrochlorothiazide—hypertension	0.000175	0.000731	CcSEcCtD
Methylnaltrexone—Nausea—Furosemide—hypertension	0.000172	0.000719	CcSEcCtD
Methylnaltrexone—Abdominal pain—Lisinopril—hypertension	0.000172	0.000718	CcSEcCtD
Methylnaltrexone—Nausea—Betaxolol—hypertension	0.00017	0.000712	CcSEcCtD
Methylnaltrexone—Nausea—Losartan—hypertension	0.000166	0.000694	CcSEcCtD
Methylnaltrexone—Diarrhoea—Ramipril—hypertension	0.000164	0.000685	CcSEcCtD
Methylnaltrexone—Diarrhoea—Timolol—hypertension	0.00016	0.00067	CcSEcCtD
Methylnaltrexone—Dizziness—Ramipril—hypertension	0.000158	0.000662	CcSEcCtD
Methylnaltrexone—Dizziness—Timolol—hypertension	0.000155	0.000648	CcSEcCtD
Methylnaltrexone—Vomiting—Ramipril—hypertension	0.000152	0.000637	CcSEcCtD
Methylnaltrexone—Vomiting—Timolol—hypertension	0.000149	0.000623	CcSEcCtD
Methylnaltrexone—Diarrhoea—Lisinopril—hypertension	0.000149	0.000622	CcSEcCtD
Methylnaltrexone—Dizziness—Lisinopril—hypertension	0.000144	0.000601	CcSEcCtD
Methylnaltrexone—Nausea—Ramipril—hypertension	0.000142	0.000595	CcSEcCtD
Methylnaltrexone—Nausea—Timolol—hypertension	0.000139	0.000582	CcSEcCtD
Methylnaltrexone—Vomiting—Lisinopril—hypertension	0.000138	0.000578	CcSEcCtD
Methylnaltrexone—Nausea—Lisinopril—hypertension	0.000129	0.00054	CcSEcCtD
Methylnaltrexone—CYP2D6—Metabolism—SLC5A2—hypertension	1.9e-05	0.000126	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGIS—hypertension	1.9e-05	0.000126	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP3A5—hypertension	1.9e-05	0.000126	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CNR1—hypertension	1.89e-05	0.000125	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TGFBR2—hypertension	1.88e-05	0.000125	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CALM2—hypertension	1.87e-05	0.000124	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GNB3—hypertension	1.86e-05	0.000123	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—AKT2—hypertension	1.85e-05	0.000123	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR7—hypertension	1.84e-05	0.000122	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DRD2—hypertension	1.84e-05	0.000122	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TPH1—hypertension	1.84e-05	0.000122	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—UCP3—hypertension	1.84e-05	0.000122	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ABCC1—hypertension	1.84e-05	0.000122	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HSD11B1—hypertension	1.84e-05	0.000122	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—UCP2—hypertension	1.84e-05	0.000122	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AVP—hypertension	1.83e-05	0.000122	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GCG—hypertension	1.82e-05	0.000121	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTPN1—hypertension	1.82e-05	0.000121	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—RHOA—hypertension	1.82e-05	0.000121	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GNAS—hypertension	1.81e-05	0.00012	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PIK3R1—hypertension	1.8e-05	0.000119	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NOTCH2—hypertension	1.79e-05	0.000119	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—KL—hypertension	1.79e-05	0.000119	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALAS1—hypertension	1.78e-05	0.000118	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP11B2—hypertension	1.78e-05	0.000118	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SLC2A3—hypertension	1.78e-05	0.000118	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—APOB—hypertension	1.77e-05	0.000118	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PTK2—hypertension	1.77e-05	0.000117	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CXCL8—hypertension	1.76e-05	0.000117	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ITGAV—hypertension	1.76e-05	0.000116	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NGFR—hypertension	1.76e-05	0.000116	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HSD3B1—hypertension	1.75e-05	0.000116	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ADA—hypertension	1.75e-05	0.000116	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—KNG1—hypertension	1.75e-05	0.000116	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EDN1—hypertension	1.75e-05	0.000116	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—POMC—hypertension	1.74e-05	0.000116	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRL—hypertension	1.74e-05	0.000115	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AGTR1—hypertension	1.74e-05	0.000115	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL5—hypertension	1.73e-05	0.000115	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—AQP1—hypertension	1.73e-05	0.000114	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—FADS1—hypertension	1.73e-05	0.000114	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—STK11—hypertension	1.71e-05	0.000114	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HDAC1—hypertension	1.71e-05	0.000114	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL2—hypertension	1.71e-05	0.000113	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL10—hypertension	1.7e-05	0.000113	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PLG—hypertension	1.7e-05	0.000112	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—LPL—hypertension	1.69e-05	0.000112	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—RHOA—hypertension	1.69e-05	0.000112	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—H2AFX—hypertension	1.68e-05	0.000112	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TBXAS1—hypertension	1.68e-05	0.000111	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CA9—hypertension	1.68e-05	0.000111	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RPS6KB1—hypertension	1.68e-05	0.000111	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDGFRB—hypertension	1.68e-05	0.000111	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—AKT2—hypertension	1.68e-05	0.000111	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PIK3R1—hypertension	1.68e-05	0.000111	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADCY5—hypertension	1.66e-05	0.00011	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADRB2—hypertension	1.65e-05	0.00011	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRKCG—hypertension	1.65e-05	0.000109	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALOX15—hypertension	1.64e-05	0.000109	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALOX5AP—hypertension	1.64e-05	0.000109	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ITGB3—hypertension	1.64e-05	0.000109	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRKCA—hypertension	1.64e-05	0.000109	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRKCE—hypertension	1.63e-05	0.000108	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—YWHAZ—hypertension	1.62e-05	0.000108	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—VAV3—hypertension	1.61e-05	0.000107	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDGFA—hypertension	1.61e-05	0.000107	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NGF—hypertension	1.6e-05	0.000106	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SPP1—hypertension	1.6e-05	0.000106	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HADHA—hypertension	1.6e-05	0.000106	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LHB—hypertension	1.6e-05	0.000106	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CXCL8—hypertension	1.6e-05	0.000106	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TGFBR2—hypertension	1.59e-05	0.000105	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GNB3—hypertension	1.57e-05	0.000104	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—KCNJ11—hypertension	1.56e-05	0.000104	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HSD3B2—hypertension	1.56e-05	0.000104	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LPA—hypertension	1.56e-05	0.000104	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRKCD—hypertension	1.56e-05	0.000104	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR5—hypertension	1.56e-05	0.000104	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AVP—hypertension	1.55e-05	0.000103	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—RHOA—hypertension	1.54e-05	0.000102	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GNAS—hypertension	1.53e-05	0.000102	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR2A—hypertension	1.53e-05	0.000101	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—C3—hypertension	1.52e-05	0.000101	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PIK3R1—hypertension	1.52e-05	0.000101	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—APOB—hypertension	1.5e-05	9.94e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LRP2—hypertension	1.5e-05	9.93e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP2C18—hypertension	1.5e-05	9.93e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTK2—hypertension	1.49e-05	9.9e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CXCL8—hypertension	1.49e-05	9.86e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDGFB—hypertension	1.48e-05	9.85e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FGFR1—hypertension	1.48e-05	9.79e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EDN1—hypertension	1.47e-05	9.79e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL5—hypertension	1.46e-05	9.71e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HIF1A—hypertension	1.45e-05	9.65e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AGT—hypertension	1.45e-05	9.61e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HSPG2—hypertension	1.44e-05	9.56e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—LPL—hypertension	1.43e-05	9.49e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CALM1—hypertension	1.42e-05	9.45e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—H2AFX—hypertension	1.42e-05	9.43e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—LEP—hypertension	1.42e-05	9.42e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—APOE—hypertension	1.42e-05	9.42e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RPS6KB1—hypertension	1.42e-05	9.41e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDGFRB—hypertension	1.42e-05	9.41e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CAV1—hypertension	1.41e-05	9.33e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—APOA1—hypertension	1.4e-05	9.31e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADCY5—hypertension	1.4e-05	9.3e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRKCG—hypertension	1.39e-05	9.23e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GLP1R—hypertension	1.39e-05	9.23e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALOX5—hypertension	1.39e-05	9.23e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—KDR—hypertension	1.39e-05	9.23e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRKCA—hypertension	1.38e-05	9.17e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ITGB3—hypertension	1.38e-05	9.17e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—YWHAZ—hypertension	1.37e-05	9.09e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SPP1—hypertension	1.36e-05	8.99e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NGF—hypertension	1.36e-05	8.99e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL8—hypertension	1.35e-05	8.95e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRKCB—hypertension	1.34e-05	8.88e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FN1—hypertension	1.34e-05	8.88e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—F2—hypertension	1.34e-05	8.88e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR5—hypertension	1.32e-05	8.75e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRKCD—hypertension	1.32e-05	8.75e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NOTCH1—hypertension	1.31e-05	8.69e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR2A—hypertension	1.29e-05	8.56e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—C3—hypertension	1.29e-05	8.55e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALDH2—hypertension	1.27e-05	8.44e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDGFB—hypertension	1.25e-05	8.32e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FGFR1—hypertension	1.25e-05	8.28e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HBA1—hypertension	1.24e-05	8.23e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP11A1—hypertension	1.23e-05	8.17e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HIF1A—hypertension	1.23e-05	8.15e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AGT—hypertension	1.22e-05	8.12e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—POMC—hypertension	1.22e-05	8.09e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—INS—hypertension	1.21e-05	8.04e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SLC9A1—hypertension	1.21e-05	8.03e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTT1—hypertension	1.21e-05	8.03e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CALM1—hypertension	1.2e-05	7.99e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—APOE—hypertension	1.2e-05	7.96e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—LEP—hypertension	1.2e-05	7.96e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GCLC—hypertension	1.2e-05	7.94e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CETP—hypertension	1.2e-05	7.94e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL2—hypertension	1.19e-05	7.92e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CAV1—hypertension	1.19e-05	7.89e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—APOA1—hypertension	1.19e-05	7.87e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—KDR—hypertension	1.18e-05	7.8e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IGF1—hypertension	1.17e-05	7.78e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AKT2—hypertension	1.17e-05	7.78e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—EGFR—hypertension	1.17e-05	7.74e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP17A1—hypertension	1.15e-05	7.6e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ENO1—hypertension	1.13e-05	7.52e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGS1—hypertension	1.13e-05	7.52e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—F2—hypertension	1.13e-05	7.51e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FN1—hypertension	1.13e-05	7.51e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRKCB—hypertension	1.13e-05	7.51e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SERPINE1—hypertension	1.11e-05	7.39e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NOTCH1—hypertension	1.11e-05	7.34e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CTGF—hypertension	1.09e-05	7.24e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HMGCR—hypertension	1.08e-05	7.18e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GOT2—hypertension	1.08e-05	7.18e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FGF2—hypertension	1.08e-05	7.15e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RHOA—hypertension	1.07e-05	7.13e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PIK3R1—hypertension	1.06e-05	7.05e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NOS3—hypertension	1.06e-05	7.05e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ADRA2A—hypertension	1.06e-05	7.02e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—POMC—hypertension	1.03e-05	6.84e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—INS—hypertension	1.02e-05	6.8e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL2—hypertension	1.01e-05	6.69e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RELA—hypertension	1e-05	6.64e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IGF1—hypertension	9.91e-06	6.58e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TH—hypertension	9.91e-06	6.58e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AKT2—hypertension	9.9e-06	6.57e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CALM2—hypertension	9.88e-06	6.55e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—EGFR—hypertension	9.86e-06	6.54e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MTOR—hypertension	9.81e-06	6.51e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GCG—hypertension	9.64e-06	6.4e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SLC2A4—hypertension	9.64e-06	6.4e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL8—hypertension	9.43e-06	6.26e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SERPINE1—hypertension	9.41e-06	6.25e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GOT1—hypertension	9.34e-06	6.2e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FGF2—hypertension	9.11e-06	6.05e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—AKT1—hypertension	9.11e-06	6.05e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RHOA—hypertension	9.08e-06	6.02e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—STK11—hypertension	9.06e-06	6.01e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP19A1—hypertension	9.06e-06	6.01e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NOS3—hypertension	8.99e-06	5.96e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PIK3R1—hypertension	8.99e-06	5.96e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6—hypertension	8.97e-06	5.95e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MMP9—hypertension	8.53e-06	5.66e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CDKN1A—hypertension	8.5e-06	5.64e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PTEN—hypertension	8.48e-06	5.63e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RELA—hypertension	8.46e-06	5.61e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—COMT—hypertension	8.43e-06	5.59e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PPARGC1A—hypertension	8.31e-06	5.51e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GNB3—hypertension	8.31e-06	5.51e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MAPK8—hypertension	8.3e-06	5.5e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MTOR—hypertension	8.29e-06	5.5e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—AKT1—hypertension	8.27e-06	5.49e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HMOX1—hypertension	8.27e-06	5.49e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CAT—hypertension	8.16e-06	5.42e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GNAS—hypertension	8.09e-06	5.37e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EP300—hypertension	8.09e-06	5.37e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL8—hypertension	7.97e-06	5.29e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—APOB—hypertension	7.92e-06	5.26e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SRC—hypertension	7.86e-06	5.22e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTM1—hypertension	7.71e-06	5.11e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—AKT1—hypertension	7.7e-06	5.11e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—VEGFA—hypertension	7.66e-06	5.08e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6—hypertension	7.58e-06	5.03e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LPL—hypertension	7.57e-06	5.02e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ADCY5—hypertension	7.41e-06	4.91e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GPX1—hypertension	7.38e-06	4.9e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PRKCA—hypertension	7.31e-06	4.85e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP1A1—hypertension	7.31e-06	4.85e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MMP9—hypertension	7.21e-06	4.78e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CD36—hypertension	7.19e-06	4.77e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CDKN1A—hypertension	7.18e-06	4.77e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTEN—hypertension	7.17e-06	4.76e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MYC—hypertension	7.05e-06	4.68e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TGFB1—hypertension	7.03e-06	4.66e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MAPK8—hypertension	7.01e-06	4.65e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—AKT1—hypertension	6.99e-06	4.64e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EGFR—hypertension	6.89e-06	4.57e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EP300—hypertension	6.84e-06	4.54e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MTHFR—hypertension	6.81e-06	4.52e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PPARA—hypertension	6.68e-06	4.43e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SRC—hypertension	6.65e-06	4.41e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—VEGFA—hypertension	6.47e-06	4.3e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—AGT—hypertension	6.47e-06	4.29e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CALM1—hypertension	6.36e-06	4.22e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—APOE—hypertension	6.34e-06	4.21e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CAV1—hypertension	6.28e-06	4.17e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—APOA1—hypertension	6.27e-06	4.16e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MYC—hypertension	5.96e-06	3.95e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TGFB1—hypertension	5.94e-06	3.94e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EGFR—hypertension	5.83e-06	3.87e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TP53—hypertension	5.79e-06	3.84e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PPARG—hypertension	5.52e-06	3.66e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—POMC—hypertension	5.45e-06	3.61e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—INS—hypertension	5.42e-06	3.59e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6—hypertension	5.3e-06	3.52e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALB—hypertension	4.97e-06	3.3e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TP53—hypertension	4.89e-06	3.25e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AKT1—hypertension	4.89e-06	3.24e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PIK3R1—hypertension	4.75e-06	3.15e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NOS3—hypertension	4.75e-06	3.15e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6—hypertension	4.48e-06	2.97e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGS2—hypertension	4.35e-06	2.88e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AKT1—hypertension	4.13e-06	2.74e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTEN—hypertension	3.79e-06	2.51e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—EP300—hypertension	3.61e-06	2.4e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—AKT1—hypertension	2.18e-06	1.45e-05	CbGpPWpGaD
